Ignite Creation Date:
2024-05-06 @ 6:25 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05654623
Status:
RECRUITING
Last Update Posted:
2024-04-25
First Post:
2022-11-16
Brief Title:
A Study to Learn About a New Medicine Called Vepdegestrant ARV-471 PF-07850327 in People Who Have Advanced Metastatic Breast Cancer
Sponsor:
Pfizer
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Breast Cancer |
Keywords:
| Name | View |
|---|---|
| Vepdegestrant | View |
| ERHER2- Advanced Breast Cancer | View |
| Advanced cancer of the breast | View |
| Breast neoplasm | View |
| Breast tumor | View |
| Breast cancer | View |
| Fulvestrant | View |
| Estrogen receptor positive | View |
| Metastatic breast cancer | View |
| ER degrader | View |
| PROTAC | View |
| Hormone Therapy | View |
| Hormone positive breast cancer | View |
| Endocrine therapy | View |
| Recurrent breast cancer | View |
| HR | View |
| HER2-negative | View |